Related Experiment Video
Updated: Jun 22, 2026

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
[Glycopeptide-resistant Enterococcus faecium in a hospital in northern Spain. Molecular characterization and clinical
Eva Torres1, Sonia Pérez, Ana Vindel
1Servicio de Microbiología, Complejo Hospitalario Universitario A Coruña, La Coruña, España.
Introduction:
Glycopeptide resistance in Enterococcus spp. is a clinical problem because of the rapid dissemination of these microorganisms, possible transfer of vancomycin resistance to more virulent pathogens, such as Staphylococcus aureus, and the limited therapeutic possibilities for the infections they cause. In this study, 10 strains of vancomycin-resistant Enterococcus faecium isolated from 10 different patients in our hospital during 2004 to 2005 were characterized.
Methods:
PCR was used to analyze the gene implicated in glycopeptide resistance. Molecular analysis of clinical isolates was performed by pulsed-field gel electrophoresis (PFGE). The presence of genes previously associated with epidemicity/virulence (esp, hyl, asa1, gel, cyl) was also studied. Risk factors were determined in a case-control study.
Results:
The most commonly detected gene was vanA. PFGE analysis revealed 5 different genotypes (A-E), with a predominance of genotype A (n=3) and B (n=3). The esp (surface protein) and hyl (hyaluronidase) genes were detected in all strains, with the exception of genotypes B and D. The purK1 allele, associated with clonal complex 17 was demonstrated in all strains.
Conclusion:
Prior administration of cephalosporins, aminoglycosides and vancomycin alone or in combination was significantly associated with colonization/infection by vancomycin-resistant Enterococcus faecium.
Insights
Vancomycin-resistant Enterococcus faecium (VRE) infections are a significant clinical challenge. Prior antibiotic use, including vancomycin, cephalosporins, and aminoglycosides, was strongly linked to VRE colonization and infection.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Science
Context:
- Glycopeptide resistance in Enterococcus species poses a major clinical challenge due to rapid spread and limited treatment options.
- Vancomycin-resistant Enterococcus faecium (VRE) infections are difficult to treat and can transfer resistance to other pathogens.
- This study investigated VRE strains isolated from hospital patients between 2004 and 2005.
Purpose:
- To characterize vancomycin-resistant Enterococcus faecium strains isolated from clinical settings.
- To identify the genetic basis of glycopeptide resistance and potential virulence factors.
- To determine risk factors associated with VRE colonization and infection.
Summary:
- The vanA gene was the most prevalent gene associated with glycopeptide resistance.
- Pulsed-field gel electrophoresis (PFGE) identified five distinct VRE genotypes (A-E), with genotypes A and B being most common.
- Virulence genes esp and hyl were frequently detected, and the purK1 allele, linked to clonal complex 17, was present in all strains.
Impact:
- Identified specific antibiotic exposures (cephalosporins, aminoglycosides, vancomycin) as significant risk factors for VRE.
- Provides crucial data for infection control strategies and antibiotic stewardship programs.
- Highlights the importance of monitoring VRE epidemiology and resistance mechanisms in clinical settings.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Rapid Identification of Pathogens
Stringent Response in E. coli
